首页> 美国卫生研究院文献>Toxins >Factors Influencing Goal Attainment in Patients with Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study
【2h】

Factors Influencing Goal Attainment in Patients with Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study

机译:在现实生活中肉毒毒素A治疗后卒中后上肢痉挛患者目标达成的影响因素:上肢国际痉挛(ULIS)-II研究的子分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this post-hoc analysis of the ULIS-II study, we investigated factors influencing person-centred goal setting and achievement following botulinum toxin-A (BoNT-A) treatment in 456 adults with post-stroke upper limb spasticity (ULS). Patients with primary goals categorised as passive function had greater motor impairment (p < 0.001), contractures (soft tissue shortening [STS]) (p = 0.006) and spasticity (p = 0.02) than those setting other goal types. Patients with goals categorised as active function had less motor impairment (0.0001), contracture (p < 0.0001), spasticity (p < 0.001) and shorter time since stroke (p = 0.001). Patients setting goals for pain were older (p = 0.01) with more contractures (p = 0.008). The proportion of patients achieving their primary goal was not impacted by timing of first-ever BoNT-A injection (medium-term (≤1 year) vs. longer-term (>1 year)) post-stroke (80.0% vs. 79.2%) or presence or absence of severe contractures (76.7% vs. 80.6%), although goal types differed. Earlier BoNT-A intervention was associated with greater achievement of active function goals. Severe contractures impacted negatively on goal achievement except in pain and passive function. Goal setting by patients with ULS is influenced by impairment severity, age and time since stroke. Our findings resonate with clinical experience and may assist patients and clinicians in selecting realistic, achievable goals for treatment.
机译:在ULIS-II研究的事后分析中,我们调查了456名卒中后上肢痉挛(ULS)成年人中肉毒毒素A(BoNT-A)治疗后影响以人为中心的目标设定和成就的因素。主要目标为被动功能的患者比设定其他目标类型的患者具有更大的运动障碍(p <0.001),挛缩(软组织缩短[STS])(p = 0.006)和痉挛(p = 0.02)。目标归类为活动功能的患者运动障碍(0.0001),挛缩(p <0.0001),痉挛(p <0.001)和中风后时间较短(p = 0.001)较少。设定疼痛目标的患者年龄较大(p = 0.01),挛缩更多(p = 0.008)。脑卒中后首次BoNT-A注射的时间(中期(≤1年)对长期(> 1年)与长期(> 1年)对比,患者达到其主要目标的比例不受影响(80.0%vs. 79.2) %)或是否存在严重挛缩(76.7%vs. 80.6%),尽管目标类型有所不同。早期的BoNT-A干预与主动功能目标的更大实现有关。严重挛缩对目标的实现有负面影响,除了疼痛和被动功能。 ULS患者的目标设定受损伤严重程度,中风后的年龄和时间的影响。我们的发现与临床经验相呼应,可以帮助患者和临床医生选择现实可行的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号